| 000 | 01482 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250517183546.0 | ||
| 264 | 0 | _c20171204 | |
| 008 | 201712s 0 0 eng d | ||
| 022 | _a1879-1891 | ||
| 024 | 7 |
_a10.1016/j.ajo.2017.10.010 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGower, Emily W | |
| 245 | 0 | 0 |
_aGeographic and Demographic Variation in Use of Ranibizumab Versus Bevacizumab for Neovascular Age-related Macular Degeneration in the United States. _h[electronic resource] |
| 260 |
_bAmerican journal of ophthalmology _cDec 2017 |
||
| 300 |
_a157-166 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAngiogenesis Inhibitors _xadministration & dosage |
| 650 | 0 | 4 |
_aBevacizumab _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIntravitreal Injections |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aPrevalence |
| 650 | 0 | 4 |
_aRanibizumab _xadministration & dosage |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 |
_aUnited States _xepidemiology |
| 650 | 0 | 4 | _aVisual Acuity |
| 650 | 0 | 4 |
_aWet Macular Degeneration _xdiagnosis |
| 700 | 1 | _aStein, Joshua D | |
| 700 | 1 | _aShekhawat, Nakul S | |
| 700 | 1 | _aMikkilineni, Shravani | |
| 700 | 1 | _aBlachley, Taylor S | |
| 700 | 1 | _aPajewski, Nicholas M | |
| 773 | 0 |
_tAmerican journal of ophthalmology _gvol. 184 _gp. 157-166 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ajo.2017.10.010 _zAvailable from publisher's website |
| 999 |
_c27757920 _d27757920 |
||